| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90048 [N. M., H. P. K.]; Hemostasis Research Center, Catholic University of Rome, 00168 Rome, Italy [R. M.]; Department of Medicine, Clinic/Oncology, University of Doz, A-6020 Innsbruck, Austria [E. H.]; Department of Hematology/Oncology, University of Freiburg Medical Center, D-79106 Freiburg, Germany [M. L.]; Department of Hematology, Tokyo Womens Medical University, Tokyo 162, Japan [N. M., H. M.]
To elucidate the genetic events that may play an important role in the progression of myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML), we performed allelotype analysis of 24 individuals using matched MDS and AML samples from the same patients. Because the evolution can take years to occur, we used DNAs extracted from archival samples. These samples were analyzed with 79 microsatellite markers, which mapped to each of the autosomal arms except the short arms of the acrocentric chromosomes. Loss of heterozygosity on at least one locus was observed in 18 of the 24 cases (75%) as the disease progressed. Frequent allelic loss in >20% of the informative cases was observed on chromosome arms 6q (31%), 7p (23%), 10p (31%), 11q (27%), 14q (25%), and 20q (23%). Although cytogenetic information was available for many of our cases with allelic loss on 6q, 7p, 10p, 11q, 14q, and 20q, no deletions were observed on these arms. Fractional allelic loss, calculated for each sample as the total number of chromosomal arms lost per total number of arms with information, showed a median value of 0.06 and a mean of 0.15 (range, 00.59). No microsatellite instability at more than one marker was found in any of the samples. These results suggest that tumor suppressor genes exist on 6q, 7p, 10p, 11q, 14q, and 20q that have an important role in the evolution of MDS to AML when they are mutated.
This article has been cited by other articles:
![]() |
J. Rhodes, A. Amsterdam, T. Sanda, L. A. Moreau, K. McKenna, S. Heinrichs, N. J. Ganem, K. W. Ho, D. S. Neuberg, A. Johnston, et al. Emi1 Maintains Genomic Integrity during Zebrafish Embryogenesis and Cooperates with p53 in Tumor Suppression Mol. Cell. Biol., November 1, 2009; 29(21): 5911 - 5922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mohamedali, J. Gaken, N. A. Twine, W. Ingram, N. Westwood, N. C. Lea, J. Hayden, N. Donaldson, C. Aul, N. Gattermann, et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes Blood, November 1, 2007; 110(9): 3365 - 3373. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Rassool, T. J. Gaymes, N. Omidvar, N. Brady, S. Beurlet, M. Pla, M. Reboul, N. Lea, C. Chomienne, N. S.B. Thomas, et al. Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia? Cancer Res., September 15, 2007; 67(18): 8762 - 8771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Belgrader, F. Raisi, R. Joshi, P. Nguyen, W. McMillan, J. Ching, R. Chang, and M. A. Northrup Rapid and Automated Cartridge-based Extraction of Leukocytes from Whole Blood for Microsatellite DNA Analysis by Capillary Electrophoresis Clin. Chem., October 1, 2001; 47(10): 1929 - 1931. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |